Multiple lines of chemotherapy are the main risk factor for severe infections in patients with chronic lymphocytic leukemia with febrile episodes

Haematologica

Volumn 90, Issue 8, 2005, Pages 1145-1147

  Molteni, Alfredo ^a   Nosari, Annamaria ^a   Montillo, Marco ^a   Cafro, Anna ^a   Klersy, Catherine ^b   Morra, Enrica ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Chronic lymphocytic leukemia; Febrile episodes; FUO; Infections

Indexed keywords

ACICLOVIR; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; FLUDARABINE; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PYREXIA IDIOPATHICA; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; FEVER; HUMANS; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 24944503543     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chapel HM, Bunch C, Mechanism of infection in chronic lymphocytic leukaemia. Semin Hematol 1987;24:291-6.
2. Morra E, Nosari A, Montillo M. Infectious complications in chronic lymphocytic leukaemia. Hematol Cell Ther 1999;41:145-51.
3. Itälä M, Helenius H, Nikoskelaien J, Renies K. Infections and serum IgG levels in patients with chronic lymphocytic leukaemia. Eur J Haematol 1992;48:266-70.
4. Van Scoy-Mosher MB, Bick M, Capostagno V, Walford RL, Gatti RA. A clinicopathologic analysis of chronic lymphocytic leukemia. Am J Hematol 1981;10:9-18.
5. Travade PH, Dusart JD, Cavaroe D. Les infections graves associees a la leucemie lymphoide chronique. Presse Med 1986;15:1715-8.
6. Kontoyanis DP, Anaissie EJ, Bodey GP. Infection in chronic lymphocytic leukaemia. In: Cheson BD, ed. Chronic Lymphocytic Leukemia Scientific Advances and Clinic Developments. New York, NY, Marcel Dekker, Inc., 1993. p. 399-417.
7. Anaissie EJ, Kontoyannis D, O'Brien S, Kantarjian H, Robertson L, Lerner S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998;129:559-66.
8. O'Brien SN, Blijlevens NMA, Mahfouz TH, Anaissie JE. Infections in patients with hematological cancer: recent developments. Hematology 2003;438-72.
9. Hensel M, Kornaker M, Yammeni S, Egerer G, Ho AD. Disease activity and pre-treatment rather than hypogammaglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia. Br J Haematol 2003;122:600-6.
10. Bernard CH, Mombelli G, Klastersky J. Pneumococcal bacteremia in patients with neoplastic diseases. Eur J Cancer Clin Oncol 1981;17:1041-6.